Phase 2 Fatty Liver Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA60 enrolled1 locationNCT07193927
Recruiting
Phase 2
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Non-Alcoholic Fatty Liver Disease
Justin Ryder40 enrolled1 locationNCT06355310
Recruiting
Phase 1Phase 2
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Fatty Liver
Tanta University50 enrolled1 locationNCT07242222
Recruiting
Phase 1Phase 2
Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
Fatty Liver
Tanta University50 enrolled1 locationNCT07238985
Recruiting
Phase 2
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
ObesityFatty Liver
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau30 enrolled1 locationNCT06599918
Recruiting
Phase 2
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Phase 2
Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial
Metabolic-associated Fatty Liver Disease (MAFLD)
Li Lab,MD100 enrolled2 locationsNCT06798948
Recruiting
Phase 2
Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD
Nonalcoholic Fatty Liver DiseaseHypertriglyceridemia
OrsoBio, Inc30 enrolled4 locationsNCT06564584
Recruiting
Phase 2
Effect of CoQ10 on the Outcome of MAFLD Patients
NAFLDFatty Liver
Ain Shams University60 enrolled1 locationNCT05984745
Recruiting
Phase 2
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
Non-Alcoholic Fatty Liver Disease
Tanta University46 enrolled1 locationNCT06863376
Recruiting
Phase 2
Soluble Fibre Supplementation in NAFLD
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisHepatic Steatosis
McMaster University60 enrolled1 locationNCT05480696
Recruiting
Phase 2
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisMicrobiome+4 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)48 enrolled1 locationNCT05821010
Recruiting
Phase 2
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki44 enrolled1 locationNCT06133101
Recruiting
Phase 1Phase 2
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Steatohepatitis, NonalcoholicFatty Liver Disease
Sadat City University46 enrolled1 locationNCT06302049